Stay updated on Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA minor site revision was issued (Revision: v3.4.2), replacing the previous v3.4.1 and removing the government funding lapse notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide government funding notice and upgraded from v3.4.0 to v3.4.1; this does not affect the study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary display and status indicators (Results Submitted, Last Update Submitted that Met QC Criteria, Last Update Posted) and updated the revision to v3.4.0, while removing older indicators (No Results Posted, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4).SummaryDifference0.3%

- Check42 days agoChange DetectedThe page shows a revision label updated from v3.3.3 to v3.3.4. No substantive changes to the study details or page content are evident; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a Texas site to the Locations; updated the page revision to v3.3.3 and removed the previous Texas Locations reference and HHS Vulnerability Disclosure.SummaryDifference0.2%

- Check78 days agoChange DetectedNew Study Record Dates entries were added for 2025-12-03 (Actual) and 2025-12-05 (Actual), and entries for 2025-09-11/12 were removed. These changes are administrative in nature and do not affect trial details or outcomes.SummaryDifference0.3%

Stay in the know with updates to Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Radiation in HPV+ Oropharyngeal Clinical Trial page.